StreetAlpha

Do Weinstein Stage 2 breakouts work? A backtest on 3,000 stocks

Stan Weinstein’s stage analysis splits every chart into four stages around the 30 week moving average and buys the breakout into Stage 2. We tested 1,582 full Stage 2 breakouts from 2018 to 2026 on weekly charts, using his rules and his sell signal.

Did worseStage 2 breakouts did worse than SPY in every version we tried, and each extra rule made it worse.
Breakouts1,582
Vs SPY, 26 weeks−4.06%
Trades that made money36%
Median trade−7.5%

Win rate and median trade use Weinstein’s 30 week sell rule. Unlike our other tests, these results are measured against SPY on weekly bars.

The rules we tested

  • A weekly close above the highest high of the previous 20 weeks (the base).
  • The 30 week average flat during the base and now turning up, with price above it.
  • Weekly volume at least twice the average of the previous 10 weeks.
  • Relative strength against SPY above its own 52 week average (positive Mansfield relative strength).
  • Buy at the next week’s open. Sell on a weekly close more than 3% below the 30 week average, or after two years.
  • Stocks above $5 trading at least $5 million a day on average, including companies that later stopped trading.
Stage 2 breakouts while SPY was also in Stage 2: 26 week result against SPY, by year
0%−4.00%2018−6.60%2019−2.30%2020−6.40%2021+1.20%2022−6.00%2023−2.20%2024−0.40%2025−7.00%2026

2022 had only 6 signals. 2026 runs to the latest results.

Every extra rule made it worse

  • Breakout on price alone, with the 30 week sell rule: 1.7% behind SPY per trade.
  • Adding the base, the rising average and relative strength: 3.1% behind.
  • Adding the 2x volume rule, the full Weinstein setup: 3.8% behind.
  • Requiring 3x volume: 5.6% behind SPY over 26 weeks.
  • Only buying while SPY itself was in Stage 2: 4.3% behind over 26 weeks.
  • The first pullback after a breakout: 2.0% behind per trade.

One likely reason: in this period many heavy volume breakouts were earnings gaps that faded.

What the stages are good for

The stage labels themselves do carry information. Stocks in Stage 2 while the market was also in Stage 2 did slightly better than the average stock, about 0.35% over 26 weeks, which is too small to trade. Stocks in Stage 1 and Stage 3 lagged by about 1.4% over 26 weeks. So the stages work better as a list of what to avoid than as a buy signal.

The most recent 18 months

This test covers 2018 to 2026 as one period, so there is no separate check on recent months.

What it means for your trading

  • Do not buy a breakout just because it fits the Stage 2 checklist.
  • Use the stages to stay away from Stage 1 bases and Stage 3 tops.
  • Weinstein buys during the week on buy stop orders. We bought at the next week’s open, which catches some winners later but also avoids some false breakouts.

Limits: daily closes from mid 2018, which includes one bear market (2022). Results are averages over thousands of trades; any single trade can do far better or worse.

Top MomentumThe 12 month strength list that held up best in our tests, updated every night.Open →

Weinstein stage analysis questions

What are the four Weinstein stages?

Stage 1 is a base, with price moving sideways around a flat 30 week average. Stage 2 is an advance above a rising average. Stage 3 is a top, with the average flattening again. Stage 4 is a decline below a falling average.

Do Stage 2 breakouts beat the market?

Not in our test. 1,582 full Stage 2 breakouts from 2018 to 2026 trailed SPY by 4.1% over the following 26 weeks.

What is the 30 week moving average rule?

Weinstein buys only above a rising 30 week average and sells when price closes clearly below it. With that sell rule, 36% of our trades made money and the median trade lost 7.5%.

Backtest results are hypothetical. They are based on historical prices, include a simple trading cost and leave out taxes and other costs of real trading. Past results do not guarantee future returns. For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security.